From the Departments of ∗Radiology
†Interventional Medicine, Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Chansha
‡Department of Pharmaceutical Diagnosis, GE Healthcare (China)
§Department of Radiology, Huaihua Cancer Hospital, Huaihua, Hunan Province, China.
Received for publication July 2, 2022; accepted October 13, 2022.
Correspondence to: Xiaoping Yu, PhD, Department of Radiology, Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University. No. 283 Tongzipo Rd, Yuelu District, Changsha, 410013, Hunan Province, China (e-mail: [email protected]).
S.W. and X.Y. contributed equally to this work.
This study was supported by Hunan Provincial Natural Science Foundation of China (Project Number: 2018JJ6091, 2020JJ4052).
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.jcat.org).